BECN1 and breast cancer: In fact, expression of the proautophagic protein Beclin 1 correlates with cancer prognosis where low levels are associated with a worse outcome in colorectal, pancreatic, gastric, and breast cancers and high levels of expression are associated with improved survival (95, –, 97).